Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

Auteurs

T. Grinda, A. Antoine, W. Jacot, C. Blaye, P.-H. Cottu, V. Diéras, F. Dalenc, A. Gonçalves, M. Debled, A. Patsouris, M.-A. Mouret-Reynier, A. Mailliez, F. Clatot, C. Levy, J.-M. Ferrero, I. Desmoulins, L. Uwer, T. Petit, C. Jouannaud, M. Lacroix-Triki, E. Deluche, M. Robain, C. Courtinard, T. Bachelot, E. Brain, D. Pérol, S. Delaloge